The 68 references in paper S. Ovcharenko I., E. Son A., С. Овчаренко И., Е. Сон А. (2014) “Влияние недостаточности α1-антитрипсина на поражение легких // Effects of alfa-1-antitripsin deficiency on lung disease” / spz:neicon:pulmonology:y:2011:i:5:p:79-86

1
Travis J., Salvesen G.S.Human plazma proteinase inhibitors. Ann. Rev. Biochem. 1983; 52: 655–709.
(check this in PDF content)
2
Sandhaus R.A. Elastase may play a central role in the neutrophil migration through connective tissue. In: Taylor J.C., Mittman C., eds. Pulmonary emphysema and proteolysis. Orlando F.L: Academic Press; 1997. 227–233.
(check this in PDF content)
3
Пузырев В.П., Огородова Л.М. (ред.). Генетика бронхолегочных заболеваний. (Серия монографий Российского респираторного общества; гл. ред. Чучалин А.Г.). М.: Атмосфера; 2010.
(check this in PDF content)
4
Bulletin of the World Health Organization. 1997; 75 (5): 397–415.
(check this in PDF content)
5
Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am. J. Respir. Crit. Care Med. 2003; 168: 818–900.
(check this in PDF content)
6
Kamboh M.I.Biochemical and genetic aspects of human serum α1-proteinase inhibitor protein. Dis. Markers 1985; 3: 135.
(check this in PDF content)
7
Ogushi F., Fells G.A., Hubbard R.C. et al. Z-type α1-antitrypsin in less competent then M1-type α1-antitrypsin as an inhibitor of neutrophil elastase. J. Clin. Invest. 1987; 80: 1366–1374.
(check this in PDF content)
8
Owen M.C., Brennan S.O., Lewis J.H., Carrell R.W. Mutation of antitrypsin to antithrombin α1antitrypsin Pittsburgh (358-Met->Arg), a fatal bleeding disorder. N. Engl. J. Med. 1983; 309: 694–698.
(check this in PDF content)
9
Laurell C.B., Eriksson S. The electrophoretic pattern alpha1-globulin pattern of serum in alpha l-antitrypsin deficiency. Scan. J. Clin. Lab. Invest. 1963; 15: 132–140.
(check this in PDF content)
10
Crystal R.G.Alpha-1 antitrypsin deficiency, emphysema and liver disease: genetic basis and strategies for therapy. J. Clin. Invest. 1998; 85: 1343–1352.
(check this in PDF content)
11
Gadek J.E., Fells G.A., Zimmerman R.L. et al.Anti-elastase of the human alveolar structures: implications for the protease-antiprotease theory of emphysema. J. Clin. Invest. 1981; 68: 889–898.
(check this in PDF content)
12
Svegar T., Piitulainen E., Arborelius M. Jr. Lung function in adolescents with alpha-1-antitrypsin deficiency. Acta. Paediatr. 1994; 83: 1170–1193.
(check this in PDF content)
13
Brantly M.L., Paul L.D., Miller B.H. et al. Clinical features and history of the destructive lung disease associated with alpha-1 antitrypsin deficiency of adults with pulmonary symptoms. Am. Rev. Respir. Dis 1988; 138: 327–336.
(check this in PDF content)
14
Seersholm N., Kok)Jensen A., Dirksen A.Survival of patients with severe α1-antitrypsin deficiency with special reference to non-index cases. Thorax 1994; 49: 695–698.
(check this in PDF content)
15
Piitulainen E., Torning G., Eriksson S. Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with α1-antitrypsin deficiency (PI*ZZ). Thorax 1997; 52: 244–248.
(check this in PDF content)
16
Piitulainen E., Torning G., Eriksson S.Environmental correlates of impaired lung function in non-smokers with severe α1antitrypsin deficiency (PI*ZZ). Thorax 1998; 53: 939–943.
(check this in PDF content)
17
Brandslund I., Lund E.D., Sigsgaard T.Is a low serum concentration of α1-antitrypsin associated with an increased susceptibility for byssinosis in cotton mill workers? Considerations regarding analytical quality reguirements and economical consequences. Ups. J. Med. Sci. 1993; 98: 299–310.
(check this in PDF content)
18
Sigsgaard T., Brandslund I., Rasmussen J.B. et al.Low normal α1-antitrypsin serum concentration and MZ-phenotype are associated with byssinosis and familial allergy in cotton mill workers. Pharmacogenetics 1994; 4: 135–141.
(check this in PDF content)
19
Home S.L., Tennent R.K., Cockcroft D.W. et al.Pulmonary function in PiM and MZ grainworkers. Chest 1986; 89: 795–799.
(check this in PDF content)
20
Pierre F., Pham Q.T., Mur J.M. et al. Respiratory symptoms and function in 871 miners according to Pi phenotype: a longitudinal study. Eur. J. Epidemiol. 1988; 4: 39–44.
(check this in PDF content)
21
Larsson С. Natural history and life expectancy in severe α1 antitrypsin deficiency, PiZ. Acta. Med. Scand. 1978; 204: 345–351.
(check this in PDF content)
22
Osman M., Cantor J.O., Roffman S. et al. Cigarette smoke impairs elastin resynthesis in lungs of hamsters with elastase-induced emphysema. Am. Rev. Respir. Dis. 1985; 132: 640–643.
(check this in PDF content)
23
Hautamaki R.D., Kobayashi D.K., Senior R.M., Shapiro S.D. Requirement for macrophage elastase for cigarette smokeinduced emphysema in mice. Science 1997; 277: 2002–2004.
(check this in PDF content)
24
Morrison H.M., Kramps J.A., Burnett D., Stockley R.A. Lung lavage fluid from patients with α1-proteinase inhibitor deficiency or chronic obstructive bronchitis: anti-elastase function and cell profile. Clin. Sci. 1987; 72: 373–381.
(check this in PDF content)
25
Eriksson S. Studies in α1-antitrypsin deficiency. Acta. Med. Scand. 1965; 432: 1–85.
(check this in PDF content)
26
Tobin M.J., Cook P.J.L., Hutchinson D.C.S.Alpha-1 antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. Br. J. Dis. Chest 1983; 77: 14–27.
(check this in PDF content)
27
Janus E.D., Phillips N.T., Carrel R.W. Smoking, lung function and – α1-antitrypsin deficiency. Lancet 1985; 1: 152–154.
(check this in PDF content)
28
Rawlings W. Jr., Kreiss P., Levy D. et al.Clinical, epidemiological and pulmonary function studies in alpha-1 antitrypsin deficiency subjects of PI*ZZ type. Am. Rev. Respir. Dis. 1976; 114: 945–953.
(check this in PDF content)
29
McElvaney N.G., Stoller J.K., Buist A.S. et al.Alpha-1 Antitrypsin Deficiency Study Group. Baseline characteristics of enrolles in the National Heart, Lung, and Blood Institute Registry of α1-Antitrypsin deficiency. Chest 1997; 111: 394–403.
(check this in PDF content)
30
Eden E., Mitchell D., Mehlmann B. et al. Atopy, asthma and emphysema in patients with severe α1-antitrypsin deficiency. Am. J. Respir. Crit. Care Med. 1997; 156: 68-74.
(check this in PDF content)
31
King M.A., Stone J.A., Diaz P.T. et al.Alpha-1 antitrypsin deficiency: evaluation of bronchiectasis with CT. Radiology 1996; 199: 137–141.
(check this in PDF content)
32
Guest P.J., Hansell D.M.High resolution computed tomography (HRCT) in emphysema associated with alpha-1 antitrypsin deficiency. Clin. Radiol. 1992; 45: 260–266.
(check this in PDF content)
33
Cuvelier A., Muir J.F., Hellot M.F. et al.Distribution of alpha-1-antitrypsin alleles in patients with bronchiectasis. Chest 2000; 117: 415–419.
(check this in PDF content)
34
Bienert T., Brand P., Behr J. et al.Peripheral airspace dimensions in patients with COPD. Chest 1995; 108: 998–1003.
(check this in PDF content)
35
Foster W.L., Gimenez E.I., Roubidoux M.A. et al.The emphysema: radiologic-pathologic correlations. Radiographics 1993; 13: 311–328.
(check this in PDF content)
36
Gishen P., Saunders A.J.S., Tobin M.J., Hutchison D.C.S. Alpha-1 antitrypsin deficiency: the radiological features of pulmonary emphysema in subjects of Pi-type-Z and Pi-type SZ. A survey by the British Thoracic Association. Clin. Radiol. 1982; 33: 371–377.
(check this in PDF content)
37
Guenter C.A., Welch M.H., Russel T.R. et al. The pattern of lung disease assosiated with alpha-1 antitrypsin deficiency. Arch. Intern. Med. 1968; 122: 254–257.
(check this in PDF content)
38
Wilson J.S., Galvin J.R.Normal diffusing capacity in patients with PiZ alpha-1-antitrypsin deficiency, severe airflow obstruction, and significant radiographic emphysema. Chest 2000; 118: 867–871.
(check this in PDF content)
39
Schwaiblmair M., Beinert T., Seemann M. et al. Relations between cardiopulmonary execise testing and quantitative high-resolution computed tomography associated in patients with alpha-1-antitrypsin deficiency. Eur. J. Med. Res. 1998; 3: 527–532.
(check this in PDF content)
40
Miller R.R., Muller N.L., Vedal S. et al. Limitations of computed tomography in the assessment of emphysema. Am. Rev. Respir. Dis. 1989; 139: 980–983.
(check this in PDF content)
41
Flenley D.C. Diagnosis and follow-up of emphysema. Eur. Respir. Suppl. 1998; 9: 5s–8s.
(check this in PDF content)
42
Biernacki W., Ryan M., MacNee W., Flenley D.C. Can the quantitative CT scan detect progression of emphysema? [abstract] Am. Rev. Respir. Dis. 1989; 131: A120.
(check this in PDF content)
43
Seersholm N., Kok)Jensen A. Survival in relation to lung function and smoking cassation of patients with severe hereditary α1-antitrypsin deficiency. Am. J. Respir. Crit. Care Med. 1995; 151: 369–373.
(check this in PDF content)
44
Enright P.L., Connet J.E., Kanner R.E. et al. Spirometry in the Lung Health Study. II. Determinants of short-term intraindividual variability. Am. J. Respir. Crit. Care Med. 1995; 151: 406-411.
(check this in PDF content)
45
Dirksen A., Holstein)Rathlou N.)H., Madsen F. et al. Long range correlations of serial FEV1measurements in emphysematous and normal subjects. J. Appl. Physiol. 1998; 85: 259–265.
(check this in PDF content)
46
Hutchison D.C., Tobin M.J., Cooper D., Lowe D. Longitudinal studies in α1-antitrypsin deficiency: a survey by the British Thoracic Society. In: Taylor J.C., Mittman C., eds. Pulmonary emphysema and proteolysis. Orlando F.L.: Academic Press; 1987.
(check this in PDF content)
47
Buist A.S., Burrows B., Eriksson S. et al. The natural history of air-flow obstruction in PiZ emphysema: report of an NHLBI workshop. Am. Rev. Respir. Dis. 1983; 127: S43–S45.
(check this in PDF content)
48
Seersholm N., Kok)Jensen A., Dirksen A. Decline in FEV1 among patients with severe hereditary α1-antitrypsin type PiZ. Am. J. Respir. Crit. Care Med. 1995; 152: 1922–1925.
(check this in PDF content)
49
McElvaney N.G., Crystal R.D.Clinical manifestation of α1-antitrypsin deficiency. In: Crystal RD, ed. Lung Biology in Health and Disease, Vol.88: α1-antitrypsin deficiency. New York: Marcel Dekker; 1996.
(check this in PDF content)
50
Teckman J.H., Qu D., Perlmutter D.H.Molecular pathogenesis of liver disease in α1-antitrypsin deficiency. Hepatology 1996; 24: 1504–1516.
(check this in PDF content)
51
Marcus N., Teckman J.H., Perlmutter D.H.Alpha-1 antitrypsin deficiency: from genotype to childhood disease. J. Pediatr. Gastroenterol. Nutr. 1998; 27: 65–74.
(check this in PDF content)
52
Sharp H.L.α1-antitrypsin deficiency. Hosp. Pract. 1971; 6: 83-96.
(check this in PDF content)
53
Migliazza L., Lopez S.M., Murcia J. et al. Long-term survival expectancy after liver transplantation in children. J. Pediatr. Surg. 2000; 35: 7–8.
(check this in PDF content)
54
Savige J.A., Chang L., Cook L. et al. Alpha1-antitrypsin deficiency and anti-proteinase 3 antibodies in antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis. Clin. Exp. Immunol. 1995; 100: 194–197.
(check this in PDF content)
55
Esnault V.L.M., Audrain M.A.P., SesboüèR.Alpha-1 antitrypsin phenotyping in ANCA-associated diseases: one of several arguments for protease / antiprotease imbalance in systemic vasculitis. Exp. Clin. Immunogenet. 1997; 14: 206–213.
(check this in PDF content)
56
Segelmark M., Elzouki A.N., Wieslander J., Eriksson S. The PiZ gene of alpha1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. Kidney Int. 1995; 48: 844–850.
(check this in PDF content)
57
World Health Organization. Alpha1-antitrypsin deficiency: memorandum from a WHO meeting. Bull. World Health Organ. 1997; 75: 397–415.
(check this in PDF content)
58
Smith К.С., Su W.P.D., Pittelkow M.R., Winkelmann R.K. Clinical and pathologic correlations in 96 patients with panniculitis, including 15 patients with deficient levels of alpha1-antitrypsin. J. Am. Acad. Dermatol. 1989; 21: 1192–1196.
(check this in PDF content)
59
Lung Health Study. Effects of smoking intervention and use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. J.A.M.A. 1994; 272: 1497–1505.
(check this in PDF content)
60
American Thoracic Society (Medical Section of the American Lung Association). Pulmonary rehabilitation1999. Am. J. Respir. Crit. Care Med. 1999; 159: 1666–1682.
(check this in PDF content)
61
Kojalima H., Geddes D.M. Erythromycin in diffuse panbronchiolitis. Thorax 1997; 52: 915–918.
(check this in PDF content)
62
Wilcke J.T., Dirksen A. The effect of inhaled glucocorticosteroids in emphysema due to α1-antitrypsin deficiency. Respir. Med. 1997; 9: 275–279.
(check this in PDF content)
63
Schwaibmaier M., Vogelmeier С. Alpha-1-antitrypsin: hope on the horizon for emphysema sufferers. Drug Ther. (NY) 1998; 12: 429–440.
(check this in PDF content)
64
Wencker M., Banik N., Buhl R., Konietzko N. Long-term treatment of α1antitrypsin deficiency-related pulmonary emphysema with human α1-antitrypsin. Eur. Respir. J. 1998; 11: 428–433.
(check this in PDF content)
65
Seersholm N., Wencker M., Banik N. et al. Does alpha1antitrypsin augmentation therapy slow the annual decline in FEV1in patients with severe hereditary alpha1-antitrypsin deficiency? Eur. Respir. J. 1997; 10: 2260–2263.
(check this in PDF content)
66
Dirksen A., Dijkman J.H., Madsen F. et al. A randomized clinical trial of α1-antitrypsin augmentation therapy. Am. J. Respir. Crit. Care Med. 1999; 160: 1468–1472.
(check this in PDF content)
67
Hosenpud J.D., Novick R.J., Breen T.J. et al. Registry of the International Society for Heart and Lung Transplantation: twelfth official report. J. Heart Lung Transplant. 1995; 14: 805–815.
(check this in PDF content)
68
Cassina P.C., Teschler H., Konietzko N. et al. Two-year results after lung volume reduction surgery in α1-antitrypsin deficiency versus smoker's emphysema. Eur. Respir. J. 1998; 12: 1028–1032. Информация об авторах
(check this in PDF content)